{"id":33,"date":"2023-03-21T20:34:35","date_gmt":"2023-03-21T20:34:35","guid":{"rendered":"https:\/\/amealzall.wpengine.com\/?page_id=33"},"modified":"2023-04-05T13:06:30","modified_gmt":"2023-04-05T13:06:30","slug":"home","status":"publish","type":"page","link":"https:\/\/americanalzheimersalliance.org\/","title":{"rendered":"Home"},"content":{"rendered":"\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Alzheimer's is a progressive and fatal disease, a devastating illness that affects millions of Americans and their families. As new and better treatments for Alzheimer's disease receive FDA approval, swift access to these disease-modifying therapies is crucial for those who have been diagnosed.\n<\/h1>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

INNOVATIVE TREATMENTS<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

There is a growing consensus in the scientific and medical communities about the clinical benefits of the removal of amyloid plaque from the brain for people living with mild cognitive impairment and early-stage Alzheimer’s disease. Clinical trial results indicate treatments taken in the early stages of Alzheimer’s can deliver more time to participate in daily life and remain Independent.<\/p>

In 2022 the Centers for Medicare & Medicaid Services (CMS) issued a national coverage determination (NCD) that severely restricts patient access to FDA-approved medications that target amyloid plaque. Recently, there was a request to CMS to allow access for patients\u00a0 with Alzheimer\u2019s disease., CMS declined to take action.<\/p>

We are the American Alzheimer\u2019s Alliance, and we are calling on Congress and the Biden Administration to tell the Centers for Medicare & Medicaid Services (CMS) to reconsider the national coverage determination to allow access to medicines for patients with Alzheimer\u2019s Disease.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

ABOUT US<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

The American Alzheimer\u2019s Alliance is working to find solutions for the millions of people living with this devastating disease.\u00a0<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

Alzheimer’s is a progressive and fatal disease, a devastating illness that affects millions of Americans and their families. As new and better treatments for Alzheimer’s disease receive FDA approval, swift access to these disease-modifying therapies is crucial for those who have been diagnosed. INNOVATIVE TREATMENTS There is a growing consensus in the scientific and medical […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"elementor_header_footer","meta":{"footnotes":""},"class_list":["post-33","page","type-page","status-publish","hentry"],"featured_image_src":null,"featured_image_src_square":null,"_links":{"self":[{"href":"https:\/\/americanalzheimersalliance.org\/index.php?rest_route=\/wp\/v2\/pages\/33","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/americanalzheimersalliance.org\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/americanalzheimersalliance.org\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/americanalzheimersalliance.org\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/americanalzheimersalliance.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=33"}],"version-history":[{"count":0,"href":"https:\/\/americanalzheimersalliance.org\/index.php?rest_route=\/wp\/v2\/pages\/33\/revisions"}],"wp:attachment":[{"href":"https:\/\/americanalzheimersalliance.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=33"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}